Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market Size, Market Forecast and Outlook by FMI
The exoskeleton and rehabilitation robot safety and performance test equipment market was valued at USD 120.8 million in 2025 and is expected to reach USD 132.5 million by 2026. It is projected to expand at a 9.7% CAGR from 2026 to 2036 and reach USD 333.0 million by 2036. Mechanical safety testing is expected to lead with a 31.0% share in 2026, while lower-limb systems are projected to account for 38.0% of the robot type segment.
Summary of Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market
- Demand and Growth Drivers
- Rising use of rehabilitation robots is expected to support demand for specialized test equipment as manufacturers need stronger proof of safety and repeatable performance before wider deployment.
- Tighter documentation requirements are likely to remain an important market driver, especially as software checks and revalidation work gain importance across device updates.
- Interest from hospitals and rehabilitation centers is expected to support adoption of integrated testing platforms designed to assess gait response and calibration stability.
- Product and Segment View
- Mechanical safety testing is expected to remain the leading test segment, supported by the need to verify load tolerance, fatigue resistance, and safe operation in human-contact devices.
- Lower-limb systems are projected to lead the robot type segment, driven by continued focus on gait recovery and mobility restoration programs.
- OEM validation is expected to lead the main end-use segment since most qualification spending stays concentrated in product development, release preparation, and post-modification checks.
- Geography and Competitive Outlook
- China is expected to stay a high-growth market due to stronger standards activity and rising investment in medical robotics development.
- Japan is likely to stay a key market, supported by aging-related rehabilitation demand and continued public support for care and mobility robotics.
- Suppliers with strong application support and the ability to adapt testing systems to specific device designs are expected to improve their market position through the forecast period.
- Analyst Opinion
- , Associate Vice President at FMI says, “Demand for exoskeleton and rehabilitation robot safety and performance test equipment is expected to rise as developers face tighter validation requirements and greater pressure to demonstrate repeatable device performance. Companies that can support both mechanical verification and software-linked testing workflows are likely to strengthen their position as clinical robotics programs move toward wider adoption.”
- Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market Value Analysis
- The exoskeleton and rehabilitation robot safety and performance test equipment market is moving from a narrow validation niche toward a more established medical device support category.
- Demand is being supported by rising use of lower-limb rehabilitation systems and the need to verify safe human-device interaction before wider placement.
- The market is gaining from stronger focus on software checks, repeatability, and documented performance across product updates.
- Spending is supported by the need for test platforms that can help manufacturers meet safety expectations, quality requirements, and clinical-use standards over time.
Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market Definition
This market covers equipment and software used to test the safety, performance, and repeatability of powered exoskeletons and rehabilitation robots before commercial release, during design updates, and across service life verification.
Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market Inclusions
Included in scope are benchtop and floor-mounted test benches, force platforms, motion analysis hardware, wearable simulators, calibration tools, environmental and endurance fixtures, data acquisition modules, validation software, and bundled engineering services delivered specifically for exoskeleton and rehabilitation robot qualification.
Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market Exclusions
Excluded from scope are the exoskeletons and rehabilitation robots themselves, routine physiotherapy devices without a verification function, generic laboratory instruments sold without market-specific adaptation, and broad hospital diagnostics that are not procured for robotics testing.
Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market Research Methodology
- Primary Research: Research design for this assessment relied on triangulation across public health demand indicators, rehabilitation burden statistics, medical device quality requirements, and current company activity in exoskeleton and rehabilitation robotics.
- Desk Research: Desk research combined official public health data, standards and regulatory updates, public company press releases, and active vendor verification from current websites.
- Market Sizing and Forecasting: Sizing was built from a bottom-up view of validation spend attached to exoskeleton and rehabilitation robot development, release testing, and service requalification.
- Data Validation and Update Cycle: Cross-checks were applied against rehabilitation need, stroke burden, reimbursement progress, standards activity, and the current footprint of leading suppliers.
Why is the Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market Growing?
- Clinical rehabilitation demand is expanding and pushes robot makers to prove safer and more repeatable patient interaction.
- Regulators and payers now expect stronger documentation around device quality, software control, and revalidation after updates.
- Hospital buyers increasingly prefer integrated proof of gait response, calibration stability, and service readiness before adoption.
Market expansion is tied to the steady shift of rehabilitation robotics from pilot use into broader clinical evaluation and hospital adoption. As exoskeleton and rehabilitation robot programs move closer to routine use, manufacturers need better evidence on load performance and repeat behavior under continued operation. This is raising demand for specialized systems used to test structural safety, gait response, and calibration stability before release or wider placement.
Regulatory pressure is adding another layer of support. Quality systems now place greater emphasis on traceable verification, especially for devices that combine hardware with software-driven control. That is increasing the value of equipment used for fatigue checks, control testing, and documented validation after design changes. Spending is supported by the need to maintain reliable records across product development and field updates.
Market Segmental Analysis
- Mechanical safety testing is expected to account for 31.0% of the market in 2026, reflecting the importance of load checks, fatigue validation, and safe operation in human-contact rehabilitation devices.
- Lower-limb systems are projected to lead demand with a 38.0% share, supported by continued use in gait recovery and mobility restoration programs.
- Direct sales remain the leading channel, which reflects the technical nature of procurement and the need for application support during installation and validation.
The exoskeleton and rehabilitation robot safety and performance test equipment market is segmented by test type, equipment format, robot type, end user, and sales channel. Test type includes mechanical safety, functional performance, usability validation, sensor calibration, and endurance testing. By equipment format, the market includes benchtop rigs, gait labs, wearable simulators, force platforms, and integrated suites. Robot type covers lower-limb systems, upper-limb systems, gait trainers, balance trainers, and pediatric systems.
Insights into the test type segment
- Mechanical safety is expected to account for 31.0% share in 2026. Wearable robots and rehabilitation platforms operate in direct physical contact with vulnerable users. This makes structural proof, joint loading evidence, and fatigue behavior the first requirement before broader functional claims gain relevance.
- Load cells and torque verification stay core purchases even for manufacturers that later add more advanced gait replay or software validation layers.
Insights into the equipment format segment
- Benchtop rigs are projected to contribute 34.0% of total market share in 2026. Their lead reflects how many manufacturers still need compact platforms for actuator checks and joint movement validation before shifting to larger integrated environments.
- Benchtop formats fit earlier development budgets and can be used more often during firmware updates, spare-part qualification, and supplier change review.
Insights into the robot type segment
- Lower-limb systems are anticipated to represent 38.0% of the market in 2026. Gait restoration is the most visible and commercially established use case in rehabilitation robotics.
- Test equipment spending follows the device class with the greatest need for body-weight support validation and repeated cycle endurance.
Insights into the end user segment
- OEMs are likely to secure 42.0% share in 2026. The leading budget center remains inside manufacturers because safety and performance evidence is needed before release, during international expansion, and after hardware or software modifications.
- Rehabilitation hospitals buy validation tools. They usually prefer training and service-focused systems over full engineering suites.
Insights into the sales channel segment
- Direct sales are set to make up 61.0% of the market in 2026. Manufacturers want test sequences adapted to device architecture and documentation expected by regulators or notified bodies. This makes standard catalog selling less effective than engineering-led selling.
- Direct relationships help suppliers add calibration and method development revenue around the hardware base.
Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market Drivers, Restraints, and Opportunities
- Rising rehabilitation demand and tighter quality requirements are increasing the need for test systems used to verify safety, repeatability, and device readiness before wider clinical use.
- High system cost and long consultative selling cycles continue to limit faster adoption, especially among smaller developers with staged validation budgets.
- Greater focus on software-linked verification is opening new opportunity for suppliers offering integrated platforms for mechanical checks, motion analysis, and control validation.
The market is advancing through clinical need and documentation pressure across hospitals and specialist centers. Demand continues to build as manufacturers seek stronger proof of safe human-device interaction and more reliable evidence for performance under repeated use. Even with a relatively small installed base, opportunity stays visible in gait systems and revalidation after product updates.
Clinical Rehabilitation Expansion
A larger rehabilitation pipeline is pushing demand for more structured validation methods. As exoskeletons and rehabilitation robots move closer to routine use, manufacturers need tools that can measure load response and motion repeatability in realistic operating conditions. This keeps demand firm for systems used during development, release preparation, and periodic requalification.
Cost and Procurement Constraints
Market expansion is held back by the high cost of specialized validation equipment and the narrow customer base for advanced systems. Smaller developers often begin with compact test setups or outsourced validation work before moving to full integrated platforms. This slows conversion and keeps purchase timing closely tied to funding cycles and product maturity.
Integrated Validation Opportunity
A clear opportunity is forming around systems that combine structural testing and control analysis. Manufacturers increasingly want platforms that can evaluate movement quality and software behavior within one workflow. Suppliers able to support this broader validation need are likely to gain from rising demand for more connected and application-specific test environments.
Analysis of Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market by Key Countries
.webp "Top Country Growth Comparison Exoskeleton And Rehabilitation Robot Safety And Performance Test Equipment Market Cagr (2026 2036)")
| Country |
CAGR |
| China |
11.0% |
| Japan |
10.2% |
| United States |
9.8% |
| Germany |
9.1% |
| France |
8.9% |
| United Kingdom |
8.7% |
Source: Future Market Insights competitive analysis, 2026.
Analysis of Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market CAGR Analysis by Countries
- China leads with 11.0% CAGR, while Japan follows at 10.2% CAGR due to stronger robotics and standards activity.
- The United States is projected to expand at 9.8% CAGR, supported by reimbursement progress and deeper rehabilitation infrastructure.
- Germany is expected to grow at 9.1% CAGR, while France records 8.9% CAGR through the forecast period.
- The United Kingdom posts 8.7% CAGR, against the global market growth rate of 9.7% CAGR through 2036.
The global exoskeleton and rehabilitation robot safety and performance test equipment market is expected to grow at a 9.7% CAGR from 2026 to 2036. The study tracks demand across key countries, with the leading markets outlined below.
Demand Outlook for Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market in China
China is projected to expand at a 11.0% CAGR through 2036. Demand is rising as investment in medical robots grows standards activity moves faster across active medical devices. Local manufacturers are investing earlier in traceable test methods, which supports spending on safety and performance validation systems. A large rehabilitation need base and growing domestic device innovation continue to strengthen the market outlook.
- Faster standards activity is supporting earlier investment in validation tools.
- Domestic medical robotics programs are widening the need for proof-based testing.
- Policy support for high-end devices is improving long-term demand visibility.
Demand Outlook for Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market in Japan
Japan is expected to register a 10.2% CAGR over the forecast period. Demand is supported by an aging population, strong engineering capability, and continued adoption of eldercare assistive robots across care settings. Companies and institutions in Japan place high value on repeatable performance records. This favors test equipment used for documentation, calibration, and safe device behavior. Public support for robotics adoption is also helping create a stronger setting for rehabilitation robot validation demand.
- Aging-related rehabilitation demand is supporting device development activity.
- Funding support for care robotics is improving market familiarity.
- Reliable performance documentation remains important in procurement decisions.
Demand Outlook for Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market in the United States
The United States is forecast to grow at a 9.8% CAGR through 2036. The market benefits from a deeper rehabilitation infrastructure, broader reimbursement progress, and stronger access to specialist hospitals working with wearable medical devices. Demand for validation systems is supported by tighter process expectations under current quality requirements. These conditions are encouraging manufacturers to invest in equipment that can document safe operation, repeatability, and performance consistency before wider deployment.
- Reimbursement progress is improving confidence in exoskeleton adoption.
- Specialist hospitals and OEMs support a deeper validation spending base.
- Quality-system pressure is strengthening demand for traceable test workflows.
Demand Outlook for Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market in Germany
Germany is projected to grow at a 9.1% CAGR through 2036. Demand is supported by a mature rehabilitation structure and a healthcare environment that values documented device performance. The country benefits from more visible payer movement in exoskeleton access. This is encouraging stronger evidence generation before scale-up. Test equipment demand is likely to depend on safety verification, repeatability assessment, and clinical-readiness checks across wearable medical robots.
- Structured rehabilitation pathways support consistent device evaluation activity.
- Payer movement is increasing pressure for stronger validation evidence.
- Engineering-led procurement supports demand for repeatable test methods.
Demand Outlook for Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market in France
France is expected to record 8.9% CAGR during the forecast period. Demand is supported by a sizeable rehabilitation care burden and steady interest from hospitals and research centers evaluating mobility recovery technologies. The market is likely to stay more measured than Germany. Clinical need continues to support investment in validation systems linked to gait recovery and assisted rehabilitation. Suppliers with practical testing workflows and application support are likely to gain better traction in a healthcare setting shaped by broader use of physiotherapy equipment.
- Rehabilitation demand continues to support evaluation of gait-focused platforms.
- Hospital and research use remains more visible than local supplier concentration.
- Practical validation support is likely to matter in supplier selection.
Demand Outlook for Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market in the United Kingdom
The United Kingdom is projected to expand at an 8.7% CAGR through 2036. Demand is supported by organized stroke care pathways and growing interest in technologies that can show safe and measurable rehabilitation outcomes. This increases the importance of validation systems tied to clinician use, training support, and dependable performance records. The market is likely to progress steadily as rehabilitation centers evaluate more evidence-backed programs connected with wearable healthcare devices.
- Stroke pathway reform supports interest in measurable rehabilitation technologies.
- Procurement remains selective and favors well-supported validation systems.
- Clinician-linked training support can improve equipment acceptance.
Competitive Landscape and Strategic Positioning
- DIH Medical holds a leading position due to its broad rehabilitation technology exposure and stronger alignment with clinical validation workflows.
- Tyromotion, Ekso Bionics, Lifeward, and CYBERDYNE remain important participants with visible positions in rehabilitation robotics and exoskeleton-centered applications.
- Smaller players are focusing on specialized validation needs such as custom fixtures, pediatric systems, and mixed hardware-software testing environments.
DIH Medical benefits from broad rehabilitation technology exposure and stronger workflow familiarity across therapy environments. Tyromotion holds a solid market position through rehabilitation platform adjacency and international commercial reach. Ekso Bionics and Lifeward remain well placed in exoskeleton-centered applications, while CYBERDYNE brings strength through its medical HAL platform and related validation needs.
Barriers include a relatively small installed base, long consultative selling cycles, strict documentation requirements, and the need for application-specific validation methods. Strategic priorities across the market include improving workflow integration, expanding software-linked verification, and strengthening service support around calibration, training, and requalification.
Key Companies in Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market
The market includes global rehabilitation technology vendors, focused exoskeleton manufacturers, and specialist suppliers that sit close to clinical robotics development.
- DIH Medical holds a leading position due to its broad rehabilitation technology exposure and stronger alignment with clinical validation workflows.
- Tyromotion, Ekso Bionics, Lifeward, and CYBERDYNE remain important participants with visible positions in rehabilitation robotics and exoskeleton-centered applications.
- Smaller players are focusing on specialized validation needs such as custom fixtures, pediatric systems, and mixed hardware-software testing environments.
DIH Medical benefits from broad rehabilitation technology exposure and stronger workflow familiarity across therapy environments. Tyromotion holds a solid market position through rehabilitation platform adjacency and international commercial reach. Ekso Bionics and Lifeward remain well placed in exoskeleton-centered applications, while CYBERDYNE brings strength through its medical HAL platform and related validation needs.
Barriers include a relatively small installed base, long consultative selling cycles, strict documentation requirements, and the need for application-specific validation methods. Strategic priorities across the market include improving workflow integration, expanding software-linked verification, and strengthening service support around calibration, training, and requalification.
Competitive Benchmarking: Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market
| Company |
Application Breadth |
Validation Support |
Portfolio Depth |
Geographic Footprint |
| DIH Medical (Hocoma) |
High |
High |
Strong |
Global |
| Tyromotion |
High |
Medium |
Strong |
Global |
| Ekso Bionics |
Medium |
High |
Strong |
Global |
| Lifeward |
Medium |
High |
Moderate |
Global |
| CYBERDYNE |
Medium |
High |
Moderate |
Multi-region |
| Fourier Intelligence |
High |
Medium |
Moderate |
Global |
| Rex Bionics |
Low |
Medium |
Low |
Regional |
| MediTouch |
Low |
Medium |
Low |
Regional |
| Bioness |
Low |
Medium |
Low |
Multi-region |
| Motek |
Medium |
High |
Moderate |
Global |
Source: Future Market Insights competitive analysis, 2026.
Key Developments in Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market
- In February 2025, Ekso Bionics named NSM the exclusive U.S. CRT distributor for Ekso Indego Personal, broadening reimbursement-facing channel access.
- In February 2025, Lifeward finalized a reimbursement agreement with BARMER, adding 8.5 million covered lives in Germany for personal exoskeleton access.
Key players in the Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market
Major global players
- DIH Medical (Hocoma)
- Tyromotion
- Ekso Bionics
- Lifeward
- CYBERDYNE
Key emerging players/startups
- Fourier Intelligence
- Rex Bionics
Report Scope and Coverage
| Parameter |
Details |
| Quantitative Units |
USD 132.5 million to USD 333.0 million, at a CAGR of 9.7% |
| Market Definition |
The exoskeleton and rehabilitation robot safety and performance test equipment market covers equipment and software used to test safety, performance, repeatability, and release readiness of powered exoskeletons, gait trainers, and rehabilitation robots. |
| Regions Covered |
North America, Europe, East Asia, Asia Pacific |
| Countries Covered |
United States, Germany, France, United Kingdom, China, Japan, Australia |
| Key Companies Profiled |
DIH Medical (Hocoma), Tyromotion, Ekso Bionics, Lifeward, CYBERDYNE, Fourier Intelligence, Rex Bionics |
| Forecast Period |
2026 to 2036 |
| Approach |
Bottom-up market sizing built on rehabilitation burden, standards activity, reimbursement progress, and current supplier positioning across key countries and end-use settings. |
Source: Future Market Insights competitive analysis, 2026.
Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market by Segments
Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market segmented as Test Type
- Mechanical safety
- Functional performance
- Usability validation
- Sensor calibration
- Endurance testing
Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market classified by Equipment Format
- Benchtop rigs
- Gait labs
- Wearable simulators
- Force platforms
- Integrated suites
Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market analyzed by Robot Type
- Lower-limb systems
- Upper-limb systems
- Gait trainers
- Balance trainers
- Pediatric systems
Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market classified by Sales Channel
- Direct sales
- Channel partners
- Service contracts
Exoskeleton and Rehabilitation Robot Safety and Performance Test Equipment Market by Region and Country
- North America
- Latin America
- Brazil
- Chile
- Rest of Latin America
- Western Europe
- Germany
- UK
- Italy
- Spain
- France
- Nordic
- BENELUX
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- Hungary
- Balkan & Baltic
- Rest of Eastern Europe
- East Asia
- South Asia and Pacific
- India
- ASEAN
- Australia & New Zealand
- Rest of South Asia and Pacific
- Middle East & Africa
- Kingdom of Saudi Arabia
- Other GCC Countries
- Turkiye
- South Africa
- Other African Union
- Rest of Middle East & Africa
Research Sources and Bibliography
- Ekso Bionics Holdings, Inc. (2025, February 10). NSM named exclusive distributor of Ekso Indego® Personal within the CRT industry.
- Lifeward Ltd. (2025, February 5). Lifeward finalizes personal exoskeleton reimbursement agreement with BARMER, adding 8.5 million covered lives in Germany.
- World Health Organization. (2024, January 2). Assistive technology.
- Centers for Disease Control and Prevention. (2024, October 24). Stroke facts.
The bibliography is provided for reader reference.
This Report Answers
- Current market sizing and forecast for specialized safety and performance test equipment.
- Segment demand by test type, equipment format, robot type, end user, and channel.
- Country analysis across seven priority geographies with modeled CAGR ranges.
- Competitive assessment of active companies and positioning across the workflow.
- Regulatory, standards, and reimbursement factors shaping procurement timing.
- Whitespace in mixed hardware and software verification environments.
- Supply-side implications of broader rehabilitation robotics adoption.
- Decision-useful evidence for vendors, investors, and strategy teams.
Frequently Asked Questions
What is the estimated size of the market in 2026?
The market is estimated at USD 132.5 million in 2026 based on modeled demand for qualification and requalification tools.
What is the projected value by 2036?
The market is projected to reach USD 333.0 million by 2036 as validation workflows deepen across clinical robotics programs.
What CAGR is expected from 2026 to 2036?
The market is expected to expand at a CAGR of 9.7% during the 2026 to 2036 period.
Which test segment leads the market?
Mechanical safety testing leads the market because structural proof and fatigue evidence remain the first buying gate.
Which end user leads demand?
OEMs lead demand since design verification and release testing are still concentrated before wider clinical deployment.
Which countries are rising fastest?
China and Japan are rising fastest due to stronger standards activity, robotics support, and aging-linked rehabilitation demand.
